Two recombinant humanized anti-MAdCAM-1 mAbs, PF-00547659 and SHP64/Ontamlimab, are used for treating patients with inflammatory bowel disease (ulcerative colitis and Crohn’s disease) [58,59,60,61,62]. The gene discussed is MADCAM1; the disease is inflammatory bowel disease.